Premium
Case report: A kidney transplant patient with mild COVID‐19
Author(s) -
Arpali Emre,
Akyollu Basak,
Yelken Berna,
Tekin Suda,
Turkmen Aydin,
Kocak Burak
Publication year - 2020
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.13296
Subject(s) - medicine , covid-19 , population , pandemic , diabetes mellitus , coronary artery disease , intensive care medicine , mortality rate , disease , kidney transplantation , kidney transplant , kidney disease , kidney , infectious disease (medical specialty) , environmental health , endocrinology
Coronavirus Disease 2019 (COVID‐19) is currently a pandemic with a mortality rate of 1%‐6% in the general population. However, the mortality rate seems to be significantly higher in elderly patients, especially those hospitalized with comorbidities, such as hypertension, diabetes, or coronary artery diseases. Because viral diseases may have atypical presentations in immunosuppressed patients, the course of the disease in the transplant patient population is unknown. Hence, the management of these patients with COVID‐19 is an area of interest, and a unique approach is warranted. Here, we report the clinical features and our treatment approach for a kidney transplant patient with a diagnosis of COVID‐19. We believe that screening protocols for SARS‐Cov‐2 should be re‐evaluated in patients with solid‐organ transplants.